Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025)

Arcellx (ACLX) recorded quarterly Other Non-Current Liabilities of $3.4 million in Q1 2025, down 60.0% quarter-over-quarter from $8.6 million in Q4 2024, and down 77.78% on a YoY basis from $15.5 million in Q1 2024.

Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2025.

  • In Q1 2025, Other Non-Current Liabilities fell 77.78% year-over-year to $3.4 million; the TTM figure through Mar 2025 stood at $3.4 million (down 77.78% YoY), while the FY2024 annual figure was $8.6 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was $3.4 million for Q1 2025 at Arcellx, down from $8.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $15.5 million in Q1 2024 to a low of $117000.0 in Q2 2022.
  • Historically, Other Non-Current Liabilities has averaged $7.2 million across 4 years, with a median of $6.0 million in 2024.
  • Biggest YoY gain for Other Non-Current Liabilities was 77.78% in 2025; the steepest drop was 77.78% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $178000.0 in 2021, then slumped by 34.27% to $117000.0 in 2022, then soared by 7244.44% to $8.6 million in 2024, then tumbled by 60.0% to $3.4 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $3.4 million (Q1 2025), $8.6 million (Q4 2024), and $15.0 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 3.44 Mn
Dec 31, 2024 8.59 Mn
Sep 30, 2024 15.05 Mn
Jun 30, 2024 14.90 Mn
Mar 31, 2024 15.47 Mn
Jun 30, 2022 117,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 178,000.00